Analgesic nephropathy cost-effectiveness of therapy
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[2]
Overview
Overview
There is insufficient evidence about the cost-effectiveness of therapy in analgesic nephropathy.
Cost-Effectiveness of Therapy
Cost-Effectiveness of Therapy
There is insufficient evidence about the cost-effectiveness of therapy in analgesic nephropathy.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH